The US Food and Drug Administration has also started to recognize the potential of these drugs: in 2018, they designated certain psychedelic treatments with a “breakthrough therapy” status, which means that it has therapeutic potential. Several renowned medical schools and hospitals around the United States have also opened psychedelic medicine departments which have been entirely devoted to studying the impact of psilocybin and LSD.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…